Integra Lifesciences Holdings (IART) Current Leases (2019 - 2026)

Integra Lifesciences Holdings has disclosed Current Leases across 8 years of filings, most recently posting $13.9 million for Q1 2026.

• Current Leases for Q1 2026 came in at $13.9 million, down 1.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.9 million (down 1.69% YoY), and the FY2025 annual result was $14.0 million, down 3.58% from the prior year.
• Current Leases came in at $13.9 million for Q1 2026 at Integra Lifesciences Holdings, down from $14.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $16.3 million in Q1 2024 to a low of $12.7 million in Q2 2022.
• The 5-year median for Current Leases is $14.5 million (2023), against an average of $14.4 million.
• Across the five-year window, Current Leases climbed 14.71% in 2023 and decreased 13.08% in 2025, its largest moves.
• Integra Lifesciences Holdings' Current Leases stood at $14.6 million in 2022, then gained by 4.51% to $15.3 million in 2023, then fell by 4.87% to $14.5 million in 2024, then retreated by 3.58% to $14.0 million in 2025, then declined by 0.62% to $13.9 million in 2026.
• The last three Current Leases figures came in at $13.9 million (Q1 2026), $14.0 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.